Clinical Trials

NCT06902480 | NOT_YET_RECRUITING | NA

24 Participants

Dairy Choline Bioavailability

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-11-30

Completion: 2026-08-31

Conditions

Post-menopausal Women Post-menopausal Status

Interventions

DIETARY_SUPPLEMENT

No Results Yet

NCT06895681 | NOT_YET_RECRUITING

50000 Participants

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

Study Type: OBSERVATIONAL

Last Updated: 2025-11-10

Start Date: 2026-01-31

Completion: 2035-12-31

Conditions

Solid Tumor Solid Tumor, Adult Somatic Mutation Solid Tumor, Unspecified, Adult Hereditary Cancer

Interventions

PROCEDURE OTHER

No Results Yet

NCT06883305 | RECRUITING | PHASE3

990 Participants

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-03-18

Completion: 2029-03-13

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BIOLOGICAL OTHER

No Results Yet

NCT06878404 | RECRUITING | PHASE3

540 Participants

A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-21

Completion: 2026-05-27

Conditions

Arthritis, Psoriatic

Interventions

DRUG

No Results Yet

NCT06878261 | RECRUITING | PHASE3

990 Participants

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-03-25

Completion: 2029-03-13

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BIOLOGICAL OTHER

No Results Yet

NCT06878131 | RECRUITING

40 Participants

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

Study Type: OBSERVATIONAL

Last Updated: 2025-11-10

Start Date: 2025-04-18

Completion: 2026-12-22

Conditions

Colorectal Cancer

Interventions

BEHAVIORAL

No Results Yet

NCT06877676 | APPROVED_FOR_MARKETING

Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use

Study Type: EXPANDED_ACCESS

Last Updated: 2025-11-10

Conditions

Non-Muscle Invasive Bladder Neoplasms

Interventions

DRUG

No Results Yet

NCT06876259 | NOT_YET_RECRUITING | NA

300 Participants

Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-11-30

Completion: 2026-11-30

Conditions

Acute Otitis Media (AOM) Upper Respiratory Infection

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT06871579 | RECRUITING | NA

25 Participants

Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-06-11

Completion: 2026-01-30

Conditions

Helicobacter Pylori

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT06870812 | RECRUITING | NA

600 Participants

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-05-27

Completion: 2030-03-31

Conditions

Stroke Hemorrhagic

Interventions

PROCEDURE OTHER

No Results Yet

NCT06866288 | COMPLETED | NA

32 Participants

Belongingness in Nursing Through Mindfulness - BEING Mindful: A Pilot Study

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-04-29

Completion: 2025-10-14

Conditions

Mindfulness Sense of Belonging

Interventions

BEHAVIORAL

No Results Yet

NCT06866106 | RECRUITING | NA

50 Participants

Well-being in IBS: Strengths and Happiness (WISH) 2.0

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-10-30

Completion: 2028-04-30

Conditions

Irritable Bowel Syndrome

Interventions

BEHAVIORAL

No Results Yet

NCT06864858 | COMPLETED | NA

53 Participants

Clinical Evaluation of Two Cosmetic Contact Lenses

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-03-30

Completion: 2025-05-05

Conditions

Visual Acuity

Interventions

DEVICE

No Results Yet

NCT06863961 | RECRUITING | PHASE2

160 Participants

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-04-01

Completion: 2026-07-13

Conditions

Atopic Dermatitis

Interventions

DRUG

No Results Yet

NCT06863129 | RECRUITING | NA

334 Participants

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-01

Completion: 2029-06-01

Conditions

Metastatic Bone Disease

Interventions

PROCEDURE

No Results Yet

NCT06860594 | RECRUITING | PHASE1

30 Participants

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-07-30

Completion: 2027-06-30

Conditions

Astrocytoma, IDH-Mutant, Grade 2 Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant Recurrent Astrocytoma, IDH-Mutant Recurrent Astrocytoma, IDH-Mutant, Grade 3 Recurrent Astrocytoma, IDH-Mutant, Grade 4 Recurrent Glioblastoma, IDH-Wildtype

Interventions

PROCEDURE RADIATION DRUG

No Results Yet

NCT06858813 | RECRUITING | PHASE1

232 Participants

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-04-14

Completion: 2030-09-30

Conditions

Hepatocellular Cancer Squamous-Cell Non-Small Cell Lung Cancer

Interventions

DRUG

No Results Yet

NCT06855498 | RECRUITING | PHASE3

600 Participants

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-28

Completion: 2028-02-28

Conditions

Hidradenitis Suppurativa (HS)

Interventions

DRUG

No Results Yet

NCT06852222 | RECRUITING | PHASE3

600 Participants

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-06-04

Completion: 2029-06-22

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG

No Results Yet

NCT06850922 | RECRUITING | PHASE1/PHASE2

546 Participants

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2022-06-22

Completion: 2027-04-30

Conditions

Diabetic Macular Edema

Interventions

DRUG

No Results Yet

NCT06843239 | RECRUITING | PHASE2

80 Participants

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-06

Completion: 2026-12-31

Conditions

Systemic Sclerosis (SSc) Scleroderma

Interventions

BIOLOGICAL OTHER

No Results Yet

NCT06841354 | RECRUITING | PHASE3

1000 Participants

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-03-16

Completion: 2030-05-18

Conditions

Triple Negative Breast Neoplasms

Interventions

BIOLOGICAL DRUG

No Results Yet

NCT06834347 | RECRUITING | PHASE3

210 Participants

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-12

Completion: 2027-01-08

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG

No Results Yet

NCT06833294 | RECRUITING

48 Participants

GentleFit Non-Invasive Ventilation (NIV) Interface Trial

Study Type: OBSERVATIONAL

Last Updated: 2025-11-10

Start Date: 2025-10-24

Completion: 2026-10-30

Conditions

Device Ineffective Device Induced Injury

Interventions

DEVICE

No Results Yet

NCT06832618 | RECRUITING | PHASE3

240 Participants

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-06-17

Completion: 2026-07-13

Conditions

Atopic Dermatitis

Interventions

DRUG

No Results Yet

NCT06824181 | RECRUITING | PHASE3

580 Participants

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-27

Completion: 2027-08-26

Conditions

Pneumococcal Immunization

Interventions

BIOLOGICAL

No Results Yet

NCT06822426 | RECRUITING | PHASE3

200 Participants

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-05-14

Completion: 2027-01-31

Conditions

Central Line Associated Blood Stream Infections (CLABSI)

Interventions

DRUG

No Results Yet

NCT06822374 | WITHDRAWN | PHASE2/PHASE3

0 Participants

Hypertonic Saline in Posterior Spinal Fusion

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-12-31

Completion: 2028-05-31

Conditions

Scoliosis Idiopathic Scoliosis;Congenital

Interventions

DRUG

No Results Yet

NCT06821997 | RECRUITING | PHASE2

20 Participants

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-12-01

Completion: 2027-03-01

Conditions

Borderline Resectable Pancreatic Ductal Adenocarcinoma

Interventions

PROCEDURE DRUG

No Results Yet

NCT06817382 | RECRUITING | PHASE1

12 Participants

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-07-22

Completion: 2028-01-31

Conditions

Duchenne Muscular Dystrophy

Interventions

GENETIC

No Results Yet

NCT06813014 | NOT_YET_RECRUITING | PHASE4

400 Participants

Pharmacogenetics of Response to Sitagliptin (PRS)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2026-01-31

Completion: 2031-12-31

Conditions

Diabetes

Interventions

PROCEDURE

No Results Yet

NCT06810505 | RECRUITING | PHASE3

420 Participants

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-13

Completion: 2031-03-31

Conditions

Chronic Migraine

Interventions

DRUG

No Results Yet

NCT06809595 | RECRUITING | PHASE3

250 Participants

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-01-29

Completion: 2026-11-30

Conditions

Generalized Anxiety Disorder

Interventions

OTHER DRUG

No Results Yet

NCT06808984 | RECRUITING | PHASE2

120 Participants

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-06-09

Completion: 2027-07-27

Conditions

Agitation Alzheimer Disease

Interventions

DRUG

No Results Yet

NCT06807463 | RECRUITING | PHASE2

48 Participants

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-03-31

Completion: 2026-09-15

Conditions

Celiac Disease

Interventions

DRUG

No Results Yet

NCT06807424 | RECRUITING | PHASE3

750 Participants

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-01-09

Completion: 2027-02-10

Conditions

Arthritis, Psoriatic

Interventions

DRUG

No Results Yet

NCT06794996 | RECRUITING | PHASE2

45 Participants

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-04

Completion: 2026-12-30

Conditions

Proteinuric Kidney Disease

Interventions

DRUG

No Results Yet

NCT06792695 | RECRUITING | PHASE2

120 Participants

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-03-12

Completion: 2027-05-31

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

No Results Yet

NCT06792552 | RECRUITING | PHASE1

414 Participants

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-02-26

Completion: 2028-02-29

Conditions

Advanced Solid Tumors

Interventions

DRUG

No Results Yet

NCT06790693 | RECRUITING | PHASE3

450 Participants

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-10

Start Date: 2025-04-09

Completion: 2032-05-30

Conditions

Breast Cancer

Interventions

DRUG

No Results Yet